Finally, glucosylceramide is an independent antagonist of cellular insulin signalling, like ceramide, and seems to have a role in the development of insulin resistance, via incompletely understood mechanisms that may implicate downstream glycosphingolipids such as monosialodihexosylganglioside (GM3) [93]. The gene discussed is INS; the disease is Insulin resistance.